China Kanghui Holdings is a holding company and conducts all of its business through its two wholly owned subsidiaries in China, Changzhou Kanghui Medical Innovation Co., Ltd. (Changzhou Kanghui) and Beijing Libeier. The Company is a domestic developer, manufacturer and marketer of orthopedic implants in People's Republic of China. The Company's orthopedic implant brands are Kanghui and Libeier. It sells two lines of orthopedic implant products, trauma and spine. Its major trauma products, used in the surgical treatment of bone fractures, include a range of nails, plates and screws. Its major spine products, used in the surgical treatment of spine disorders, include screws, meshes, interbody cages and fixation systems. On July 31, 2008, we acquired 100% of the equity interests of Beijing Libeier. On July 31, 2009, the Company established Shanghai Zhikang Medical Devices Co., Ltd. (Shanghai Zhikang), which is wholly owned by Changzhou Kanghui.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:KH
CUSIPN/A
Phone+86-519-85195556
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
China Kanghui (NYSE:KH) Frequently Asked Questions
What is China Kanghui's stock symbol?
China Kanghui trades on the New York Stock Exchange (NYSE) under the ticker symbol "KH."
What is the consensus analysts' recommendation for China Kanghui?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for China Kanghui in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Has China Kanghui been receiving favorable news coverage?
Media stories about KH stock have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. China Kanghui earned a media sentiment score of 0.02 on Accern's scale. They also gave media coverage about the company an impact score of 46.63 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of China Kanghui?
Shares of KH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact China Kanghui?
China Kanghui's mailing address is No. 11 Changjiang North Road, Xinbei District, CHANGZHOU, JNG 213022, China. The company can be reached via phone at +86-519-85195556.
MarketBeat Community Rating for China Kanghui (NYSE KH)
MarketBeat's community ratings are surveys of what our community members think about China Kanghui and other stocks. Vote "Outperform" if you believe KH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KH will underperform the S&P 500 over the long term. You may vote once every thirty days.
